|Date & Time||19 May 2021 at 12:45 CEST|
Bringing innovation from the R&D phase to the market requires translational and frequently also entrepreneurial efforts. However, to realize these has long been identified as a bottle-neck resulting in a valley of death for many projects. To pass this gap, it has been proposed and discussed, to reduce the risk profile of new ventures and translational activities by providing comprehensive early-stage support schemes and structures. De-risking is also seen as an important strategy to counteract against the lack of risk capital availability throughout Europe. Though this idea is not entirely novel, as first business incubators for the life sciences were already set up in the late 90s in Europe, the concepts have been developed further and become more refined, and relevant expertise has grown as structures have institutionalised and professionalised.
The project Regions4PerMed contributes to the achievement of the objectives of the European strategy launched in 2011 with the European Council Conclusion: Towards modern, responsive and sustainable health systems (2011/C 202/04) on and modernisation of the European Healthcare system. Read more on the project here.
Registration is open here.
The program of the Workshop is based on the Conference on “Personalising Health Industry” that was held in October 2020. If you’d like to know what was discussed, the recordings of the event can be found here.